SRP4633
VEGF-C human
recombinant, expressed in E. coli, ≥90% (SDS-PAGE)
Manufacturer: Sigma Aldrich
Synonym(S): VEGFC, Vascular Endothelial Growth Factor-C
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 10 μG | SRP4633-10-μG | In Stock | ₹ 34,791.55 |
SRP4633 - 10 μG
In Stock
Quantity
1
Base Price: ₹ 34,791.55
GST (18%): ₹ 6,262.479
Total Price: ₹ 41,054.029
biological source
human
recombinant
expressed in E. coli
Assay
≥90% (SDS-PAGE)
form
lyophilized
mol wt
15-16 kDa
packaging
pkg of 10 μg
storage condition
avoid repeated freeze/thaw cycles
impurities
endotoxin, tested
NCBI accession no.
Q6FH59
shipped in
wet ice
Related Products
Description
- General description: The recombinant VEGF-C (vascular endothelial growth factor-C) is a 125 amino acid protein that lacks the N-terminal signal peptide (from T103 to R227 of Gene Bank U58111). Human VEGF-C exhibits about 85% homology with mouse VEGF-C. The VEGFC gene is mapped to human chromosome 4q34.3.[1]
- Application: VEGF-C human has been used to determine cell proliferation and survival.[2]
- Biochem/physiol Actions: VEGF-C (vascular endothelial growth factor-C) promotes tumorigenesis, by inducing lymphatic metastasis.[3] The production of VEGF-C is stimulated by pro-fibrotic transforming growth factor β. The main function of VEGF-C is to mediate lymphangiogenesis.[4] Overexpression of VEGF-C in keratinocytes of skin causes dermal lymphatic vessel hyperplasia.[5]
- Physical form: Lyophilized without additives.
- Reconstitution: Centrifuge the vial prior to opening. Avoid freeze-thaw cycles.
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
biological source: human
recombinant: expressed in E. coli
Assay: ≥90% (SDS-PAGE)
form: lyophilized
mol wt: 15-16 kDa
packaging: pkg of 10 μg
storage condition: avoid repeated freeze/thaw cycles
impurities: endotoxin, tested
NCBI accession no.: Q6FH59
shipped in: wet ice
biological source:
human
recombinant:
expressed in E. coli
Assay:
≥90% (SDS-PAGE)
form:
lyophilized
mol wt:
15-16 kDa
packaging:
pkg of 10 μg
storage condition:
avoid repeated freeze/thaw cycles
impurities:
endotoxin, tested
NCBI accession no.:
Q6FH59
shipped in:
wet ice
biological source: human
recombinant: expressed in E. coli
Assay: ≥95% (SDS-PAGE)
form: lyophilized
mol wt: ~27 kDa
packaging: pkg of 50 μg
storage condition: avoid repeated freeze/thaw cycles
impurities: endotoxin, tested
NCBI accession no.: Q6KF10
shipped in: __
biological source:
human
recombinant:
expressed in E. coli
Assay:
≥95% (SDS-PAGE)
form:
lyophilized
mol wt:
~27 kDa
packaging:
pkg of 50 μg
storage condition:
avoid repeated freeze/thaw cycles
impurities:
endotoxin, tested
NCBI accession no.:
Q6KF10
shipped in:
__
biological source: human
recombinant: expressed in E. coli
Assay: ≥98% (HPLC)≥98% (SDS-PAGE)
form: lyophilized
mol wt: ~15.4 kDa
packaging: pkg of 50 μg
storage condition: avoid repeated freeze/thaw cycles
impurities: endotoxin, tested
NCBI accession no.: P47929
shipped in: __
biological source:
human
recombinant:
expressed in E. coli
Assay:
≥98% (HPLC)≥98% (SDS-PAGE)
form:
lyophilized
mol wt:
~15.4 kDa
packaging:
pkg of 50 μg
storage condition:
avoid repeated freeze/thaw cycles
impurities:
endotoxin, tested
NCBI accession no.:
P47929
shipped in:
__
biological source: human
recombinant: expressed in E. coli
Assay: ≥95% (HPLC)≥95% (SDS-PAGE)
form: lyophilized
mol wt: ~11.2 kDa
packaging: pkg of 20 μg
storage condition: __
impurities: endotoxin, tested
NCBI accession no.: NM_001901
shipped in: __
biological source:
human
recombinant:
expressed in E. coli
Assay:
≥95% (HPLC)≥95% (SDS-PAGE)
form:
lyophilized
mol wt:
~11.2 kDa
packaging:
pkg of 20 μg
storage condition:
__
impurities:
endotoxin, tested
NCBI accession no.:
NM_001901
shipped in:
__